Pediatric rheumatology

Work productivity and activity impairment in patients under 18 with juvenile idiopathic arthritis (JIA): the international UCAN CAN-DU prospective study

Arthritis Res TherPublished Prospective cohort study

Authors' conclusion

There are substantial impacts on the ability of youth to be fully productive at work, affecting overall work impairment. In addition, there was substantial impairment in usual activities.

Study context

Population
Patients under 18 with JIA of all sub-types in the Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Diseases (UCAN CAN-DU) cohort (median age 17 years, 66% female)≥1 WPAI-SHP response
Participants
154 participants
Outcome
Work productivity and activity impairment due to JIA (WPAI-SHP): absenteeism, presenteeism, overall work impairment, activity impairment
Follow-up
Up to 12 months from enrollment
Methodological detailsinternational, multicentre, generalized estimating equations adjusted for disease activity (cJADAS10)
  • International
  • Multicentre
  • Generalized estimating equations adjusted for disease activity (cJADAS10)

Main finding

As reported in the abstract

WPAI-SHP impairment due to JIA · up to 12 months

Absenteeism (mean % work time missed)

7%

Presenteeism (% work impaired while at work)

27%

Overall work impairment

23%

Activity impairment

29%

Observational data: associations, not effects.

Further findings

Impairment by disease activity and over time

More severe JIA: greater absenteeism, and work and activity impairment
Work and activity impairment persistent over time

Original publication

Work productivity and activity impairment in patients under 18 with juvenile idiopathic arthritis (JIA): the international UCAN CAN-DU prospective study. Arthritis Res Ther. Published 27 March 2026. doi:10.1186/s13075-026-03785-y

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.